Radcliffe Capital Management, L.P. - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTAC and the CUSIP is 58507N105. A total of 10 filers reported holding MEDTECH ACQUISITION CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q3 2022$4,632,000
+13.1%
466,487
+12.1%
0.11%
+19.1%
Q2 2022$4,096,000
+1.0%
416,087
+0.6%
0.09%
+2.2%
Q1 2022$4,054,000
-0.8%
413,6870.0%0.09%
-14.0%
Q4 2021$4,087,000
-0.5%
413,6870.0%0.11%
-10.8%
Q3 2021$4,108,000
+2.2%
413,687
-0.2%
0.12%
-4.8%
Q2 2021$4,021,000
+0.4%
414,5840.0%0.13%
-21.2%
Q1 2021$4,005,000414,5840.16%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q4 2022
NameSharesValueWeighting ↓
MYDA Advisors LLC 403,070$3,910,0000.98%
Park West Asset Management LLC 1,250,000$12,125,0000.34%
SPRING CREEK CAPITAL LLC 503,600$4,885,0000.24%
ARISTEIA CAPITAL, L.L.C. 1,153,485$11,189,0000.22%
CVI Holdings, LLC 250,000$2,425,0000.16%
Context Capital Management, LLC 174,065$1,688,0000.16%
K.J. Harrison & Partners Inc 140,000$1,359,0000.14%
Radcliffe Capital Management, L.P. 414,584$4,021,0000.13%
Omni Partners US LLC 220,971$2,143,0000.09%
Vestcor Inc 276,074$2,694,0000.09%
View complete list of MEDTECH ACQUISITION CORP shareholders